XTalks
NOVEMBER 7, 2022
Liquid biopsies have demonstrated promising activity in multiple clinical settings, but the great enthusiasm and expectations around them can be harmful if not adequately managed,” said Dr. El Mustapha Bahassi, PhD, Director, Clinical Laboratory Sciences, at the global clinical research organization (CRO) Medpace.
Advarra
SEPTEMBER 23, 2022
Whether the drug’s proposed labeling (package insert) is appropriate, and what it should contain. . The FDA requires the data for these assessments to generally come from animal studies and clinical investigations 1 of the investigational product(s) 2. . The Food and Drug Administration (FDA) is the federal entity in the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
JANUARY 12, 2021
INCHEON, South Korea–( BUSINESS WIRE )– Celltrion Group today announced top-line results from its randomised, double-blind, and placebo controlled global Phase II/III clinical trial of CT-P59, an anti-COVID-19 monoclonal antibody treatment candidate. days quicker compared to placebo. days; 95% C.I, days; 95% C.I,
Camargo
NOVEMBER 29, 2021
Like with small molecules, clinical trials of biologics are designed to determine pharmacokinetics (PK), pharmacodynamics (PD), safety, and efficacy. Essentially, a biologic is a product that is produced from living organisms or that contains components of living organisms. Fusion proteins. Interferons.
The Pharma Data
JANUARY 13, 2021
Fast Track designation is well-timed, as we anticipate starting our Phase 2 clinical trial in hospitalized COVID-19 patients this month, and should help bring Brilacidin to patients faster in these dire times.”. In a human lung cell line against SARS-CoV-2, Brilacidin achieved a Selectivity Index of 426.
Drug Discovery World
SEPTEMBER 28, 2023
In fact, the endometrial fluid contains peptides that may protect against a variety of fungi, bacteria, viruses, and other pathogens 4. Earlier this year, we explored the microbiome and its role in drug development across various therapeutic areas. The influence of these microbiomes extends to children as well.
The Pharma Data
AUGUST 15, 2021
Food and Drug Administration were based on mRNA, more conventional protein-based vaccines have also shown promise in clinical trials. After characterizing the nanoparticles in vitro, they injected them into mice, along with separate polymersomes containing an adjuvant, in two doses that were three weeks apart.
Expert insights. Personalized for you.
98 
Let's personalize your content